Verenium Announces Proposed Public Offering of Co...( CAMBRIDGE Mass. Oct. 5 /- Verenium Co...)

CAMBRIDGE, Mass., Oct. 5 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNMD), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced that it intends to offer, subject to market, regulatory and other conditions, shares of its common stock, and potentially warrants, in an underwritten public offering. The offering is expected to price before 9:30 am EDT on Tuesday, October 6, 2009. Lazard Capital Markets LLC is acting as the sole book-running manager for the offering.

The securities described above are being offered by the Company pursuant to a shelf registration statement which was filed with the Securities and Exchange Commission (SEC) and became effective on January 14, 2008. A prospectus supplement describing the terms of this offering will be filed with the SEC and forms part of the effective Registration Statement.

When available, copies of the final prospectus supplement and accompanying base prospectus relating to this offering can be obtained at the SEC's website at http://www.sec.gov or from Lazard Capital Markets LLC at 30 Rockefeller Plaza, 60th Floor, New York, NY 10020.

This press release is not an offer to sell or the solicitation of an offer to buy these securities, nor shall it constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

About Verenium

Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and animal health markets. The Company possesses integrated, end-to-end capabilities and cutti
'/>"/>